FDA Approves First Treatment for Chronic Hepatitis Delta Virus Infection

THURSDAY, June 4, 2026-- The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus (HDV) infection in adults without cirrhosis or compensated cirrhosis.Hepcludex received...